Project Grant D43TW012751

Award Date 4/1/24
Completion Date 12/31/28
Dollars Obligated $1.6M
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Kenya
Similar Awards
This federal Project Grant award, funded by the National Institutes of Health (NIH) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports a comprehensive longitudinal study to assess the long-term immunologic, cardiovascular, metabolic, and neurocognitive outcomes in individuals with perinatal HIV exposure in Kenya. The $756,077 award, effective August 2024 through April 2029, aims to determine whether viral suppression on prolonged antiretroviral...
This $393,142 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support a study to explore synergies in pharmacy-based delivery of pre-exposure prophylaxis (PrEP) and contraception for adolescent girls and young women (AGYW) in Kenya. The study will be conducted by the University of Washington and involve a cluster randomized clinical trial at 20 pharmacies in...
This federal Project Grant award of $1,251,196 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to scale up an evidence-based Adolescent Transition Package (ATP) to support transitional care among youth living with HIV (YLH) in Kenya. The award will test two implementation strategies for scaling up the ATP intervention - the standard Kenya Ministry of Health implementation approach and an enhanced youth-led, data-driven...
This Project Grant award of $645,900.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) will support comprehensive research into HIV drug resistance in Kenya. The primary awardee, The Miriam Hospital, will lead the study to characterize the extent and impact of transmitted and acquired resistance to antiretroviral therapies, including the new dolutegravir-based regimens, in a large HIV care program in Kenya. The project will...
This $431,712 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to improve HIV testing among children under five in rural Uganda. The 2-year grant, awarded to the Regents of the University of California, San Francisco, will fund an innovative approach to increase pediatric HIV testing by adapting a successful traditional healer-facilitated HIV testing program for children 18 months to 5 years...
This federal Project Grant award of $685,637 from the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research aims to enhance research on inflammation and cognitive health among adolescents and young adults (AYA) living with perinatally acquired HIV (PHIV) and adversity in Uganda. The award supports a comprehensive study to investigate the relationship between immune dysfunction, inflammation, and...
This federal Project Grant award of $1,314,701.00, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to address research gaps in optimizing dolutegravir-based antiretroviral therapy (ART) for children and adolescents. The primary awardee, the University of Florida, will lead research studies to better understand dolutegravir pharmacokinetics, safety, and efficacy in pediatric and adolescent...
This $3,640,897 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund a cluster randomized trial to assess the effectiveness of a multisectoral climate-smart agricultural intervention called "Shamba Maisha" in improving reproductive and sexual health outcomes among adolescent girls and young women in Western Kenya. The intervention involves providing households with agricultural tools and...
This $815,573 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to investigate the mechanisms driving persistent inflammation in perinatally HIV-infected adolescents maintained on long-term antiretroviral therapy (ART). The goal is to identify the HIV-induced inflammatory networks and viral factors responsible for this chronic inflammation, which can lead to metabolic, neurocognitive,...
This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $113,400 to the Botswana Harvard Health Partnership (BHP) to support the development of an HIV cure research program in Botswana. The key objectives are to: 1) Identify adolescents with low HIV reservoirs or "blocked and locked" reservoir profiles, 2) Evaluate how the HIV reservoir changes over time in this adolescent cohort, and 3) Identify biomarkers...

RESEARCH TRAINING ON HIV PREVENTION AND TREATMENT IN CHILDREN AND ADOLESCENTS (UO - ABSTRACT ADOLESCENT GIRLS AND YOUNG WOMEN REPRESENT THE FASTEST GROWING POPULATION OF PERSONS LIVING WITH HIV IN KENYA, CONTRIBUTING NEARLY 40% OF NEW HIV INFECTIONS. THIS PATTERN JEOPARDIZES EFFORTS TO ADDRESS HIV IN INFANTS AND CONTRIBUTES TO THE SUSTAINED EPIDEMIC OF PEDIATRIC HIV. KENYA HAD IMPRESSIVE GAINS IN PREVENTING VERTICAL HIV TRANSMISSION IN THE EARLY YEARS OF THE EPIDEMIC, HOWEVER THESE GAINS HAVE BEEN REVERSED IN RECENT YEARS AND KENYA'S CURRENT VERTICAL HIV TRANSMISSION RATE OF >8% IS UNACCEPTABLY HIGH. IN KENYA, CLINICIAN-SCIENTISTS PLAYED A MAJOR ROLE IN ANCHORING THE EARLY HIV RESPONSE YET THERE ARE LIMITED OPPORTUNITIES FOR CAREER DEVELOPMENT IN KENYA FOR INDIVIDUALS WITH A CLINICAL BACKGROUND WHO WISH TO CONTINUE IN CLINICAL PRACTICE AND TEACHING WHILE BUILDING A RESEARCH CAREER IN AN ACADEMIC SETTING. THE MAJORITY OF SUCCESSFUL KENYAN CLINICIAN-SCIENTISTS HAVE BEEN TRAINED OVERSEAS, HIGHLIGHTING THE NEED TO DEVELOP AND SCALE-UP RESEARCH-ORIENTED TRAINING PROGRAMS IN KENYA. THIS APPLICATION THEREFORE SEEKS TO STRENGTHEN THE RESEARCH TRAINING OPPORTUNITIES IN KENYA FOR CLINICIANS WHO WANT TO DEVELOP CAREERS AS INDEPENDENT RESEARCHERS THROUGH THE PROPOSED PROGRAM, "RESEARCH TRAINING ON HIV PREVENTION AND TREATMENT IN CHILDREN AND ADOLESCENTS." THE PROGRAM WILL BE LED BY DRS. DALTON WAMALWA AND RUTH NDUATI AT THE UNIVERSITY OF NAIROBI (UON) AND CO-DIRECTED WITH DR. CAREY FARQUHAR AT UNIVERSITY OF WASHINGTON (UW), BERNARD AWUONDA AT MASENO UNIVERSITY (MU) AND KENNETH NGURE AT JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY (JKUAT). THE PROGRAM WILL OFFER LONG-TERM TRAINING WHICH INCLUDES DOCTORAL-LEVEL TRAINING IN EPIDEMIOLOGY (5 TRAINEES) AND IN BIOSTATISTICS (1 TRAINEE) AT UON (3-4 YEARS) AND MASTER'S LEVEL TRAINING IN BIOSTATISTICS (1 TRAINEE) IN SEATTLE (1.5 YEARS). THE PROGRAM WILL ALSO OFFER A 15-WEEK SYNCHRONOUS ONLINE ADVANCED CERTIFICATE IN RESEARCH TO CLINICIANS AT UON, MU AND JKUAT (DOCTORS, NURSES AND PHARMACISTS) IN MASTER'S PROGRAMS WITH AN INTEREST IN PEDIATRIC AND ADOLESCENT HIV (75 PER YEAR, 300 TOTAL), AS WELL AS A COMBINATION OF IN-PERSON ADVANCED SHORT COURSES AND WORKSHOPS CONDUCTED IN COLLABORATION WITH PARTNER INSTITUTIONS. THE PRINCIPAL INVESTIGATORS HAVE SUBSTANTIAL EXPERIENCE WITH FOGARTY TRAINING PROGRAMS AND OTHER TRAINING PROGRAMS BASED IN KENYA. THEY WILL WORK CLOSELY WITH MEMBERS OF A STEERING COMMITTEE WITH REPRESENTATIVES FROM ALL 4 INSTITUTIONS AND AN EXTERNAL TRAINING ADVISORY COMMITTEE (TAC) TO ENSURE SUCCESS OF EACH TRAINEE AND THE OVERALL PROGRAM. TOGETHER, ALL THE PARTNERS AND THE EXTENSIVE NETWORK OF FACULTY WILL WORK TOWARDS A GOAL OF STRENGTHENING EVIDENCE-BASED APPROACHES TO PREVENT AND TREAT PEDIATRIC AND ADOLESCENT HIV AND CONDUCT LOCALLY RELEVANT RESEARCH IN KENYA.

Posted 3/12/24, 12:00 AM